• Leucomycin (Kitasamycin): Mechanism and Assay Use

  2026-09-08

  Leucomycin, also called kitasamycin, is a multicomponent 16-membered macrolide that inhibits bacterial protein synthesis through the 50S ribosomal subunit. Its research value lies in controlled bacterial growth inhibition assays, translational inhibition studies, impurity analysis, and macrolide resistance characterization.

• Trichostatin A (TSA) Workflow for Epigenetic Research

  2026-09-08

  Trichostatin A (TSA) provides reversible HDAC inhibition for connecting histone acetylation with cell-cycle control, cancer-cell responses, differentiation, and immune-cell adaptation. This workflow combines a cancer-focused screening strategy with a hypoxia and glucose-deprivation model to improve assay design, interpretation, and troubleshooting.

• SIS3: Reading TGF-β/Smad3 Signaling in Context

  2026-09-07

  SIS3 is a selective Smad3 inhibitor for separating canonical TGF-β signaling from downstream phenotype. This article connects SIS3 assay design with super-enhancer-driven lung adenocarcinoma, fibrosis research, and translational model interpretation.

• Miltefosine: A Two-Pathway Research Framework

  2026-09-07

  Miltefosine is more than a PI3K/Akt pathway inhibitor: new evidence links it to Ras/MEK/ERK-driven neutrophil differentiation. This article translates the findings into practical assay, pathway-selection, and translational research decisions.

• PTT and CD47 Blockade in Oral Cancer

  2026-09-05

  This study shows that photothermal therapy (PTT) can overcome two barriers that limit CD47 blockade in oral squamous cell carcinoma: the absence of a macrophage-activating “eat me” signal and poor immune-cell access through the tumor extracellular matrix. By inducing calreticulin exposure, damage-associated molecular patterns, and extracellular matrix remodeling, PTT substantially improved macrophage phagocytosis and tumor growth control in the reported models.

• Fangchinoline Restores TFEB-Driven Lysosomal Defense

  2026-09-04

  The reference study identifies fangchinoline as a host-directed antiviral compound that restores TFEB-associated lysosomal biogenesis and interferes with H1N1 entry. Its integrated screening, lysosomal phenotyping, autophagy analysis, and time-resolved infection assays provide a mechanistic framework for targeting virus-induced lysosomal dysfunction.

• Safe DNA Gel Stain for Safer Gel Workflows

  2026-09-04

  Safe DNA Gel Stain supports sensitive DNA and RNA visualization while reducing reliance on ethidium bromide and damaging UV exposure. Its blue-light-compatible workflow is especially useful for wheat genotyping, gel extraction, cloning, and routine molecular biology nucleic acid detection.

• Regulatory NADH/NAD+ Biosensor for Bacteria

  2026-09-03

  The reference study developed a Rex-based genetically encoded biosensor that converts bacterial NADH/NAD+ redox changes into a ratiometric fluorescent signal. Its application to respiratory-chain mutants, carbon-source comparisons, and pooled enrichment demonstrates how regulatory biosensors can support noninvasive, higher-throughput analysis of bacterial metabolism.

• Fangchinoline, TFEB, and H1N1 Lysosomal Defense

  2026-09-03

  Cheng et al. identify fangchinoline as a lysosome-targeting compound that activates TFEB, restores lysosomal biogenesis, and restricts H1N1 infection. The study combines Connectivity Map screening, transcriptomic analysis, cellular trafficking assays, and in vivo validation to support a host-directed antiviral mechanism centered on endolysosomal entry.

• Linoleic Acid (C18:2) Protocol and QC Guide

  2026-09-02

  Linoleic Acid (SKU C3108) supports controlled studies of membrane behavior, oxidative stress, erythrocyte injury, cell migration, and essential fatty acid deficiency. Because it is water-insoluble and supplied as an oily liquid, it should be handled through freshly prepared ethanol or DMSO stocks rather than long-term aqueous solutions.

• L-Glutathione Reduced: Redox and GST Workflows

  2026-09-02

  L-Glutathione Reduced supports two distinct research use cases: controlled redox perturbation in cancer-metabolism experiments and competitive elution of GST-tagged proteins. Its practical value is greatest when fresh aqueous preparation, oxidation controls, and orthogonal readouts are built into the workflow.

• Cyclosporin A: Mechanism-to-Assay Design Guide

  2026-09-01

  Cyclosporin A is more than an immunosuppressive reagent: its cyclophilin–calcineurin biology can determine how apoptosis, mitochondrial, and inflammatory assays should be designed. This guide also translates lessons from a luteolin delivery study into practical decisions about controls, formulation, and interpretation.

• V5 Epitope Tag Peptide: Workflow & Troubleshooting

  2026-09-01

  The V5 Epitope Tag Peptide supports sequence-specific controls for recombinant protein expression, Western blotting, immunoprecipitation, and antibody screening. This guide turns the GKPIPNPLLGLDST peptide into a practical calibration and troubleshooting reagent, while distinguishing established immunoassays from emerging single-molecule workflows.

• SCH772984 HCl: ERK1/2 Inhibitor Workflows

  2026-08-31

  SCH772984 HCl provides a direct way to interrogate ERK1/2 signaling, from acute substrate-phosphorylation assays to longer-term viability and resistance models. This workflow-focused guide also shows how ERK perturbation can be paired with TERT, telomerase, and APEX2 assays without overstating what current evidence proves.

• Mitomycin C for Cell-Death Assay Design

  2026-08-31

  Mitomycin C is more than an antitumor antibiotic: it is a powerful perturbation tool for connecting DNA replication inhibition with measurable cell-death phenotypes. This guide translates liver cell-death biology into a rigorous assay-design framework for cancer research, colon cancer models, and apoptosis signaling research.

8025 records 1/535 page Next 12345 下5页 Last page